The anti-mTOR antibody-conjugated liposomes show potential application value in the treatment of human colon cancer. Research indicates that these liposomes can enhance the therapeutic effects on colon cancer by activating the Akt/mTOR and P53 pathways.
Anti-mTOR antibody-conjugated liposomes can potentially regulate the mTOR signaling pathway in ischemic myocardium, promoting cellular metabolism and autophagy processes, thereby improving cardiac function.
Anti-mTOR antibody conjugated liposomes hold significant promise in the treatment of adrenocortical carcinoma by enabling targeted delivery of therapeutic agents directly to cancer cells expressing the mTOR pathway. This specificity can enhance the effectiveness of the treatment while minimizing off-target effects, potentially improving patient outcomes. Moreover, the use of liposomes can facilitate the sustained release of drugs, increasing the duration of therapeutic action and potentially leading to better tumor control. Furthermore, this approach can also serve as a valuable research tool to study mTOR-related signaling pathways in adrenocortical carcinoma and identify new therapeutic targets.
Anti-mTOR antibody conjugated liposomes have significant potential in the treatment of metastatic fibrosarcoma by specifically targeting the mTOR pathway, which is often dysregulated in cancer cells. This targeted delivery mechanism enhances the therapeutic efficacy of anti-cancer agents while minimizing systemic toxicity. Additionally, the use of liposomes can improve drug solubility and stability, facilitating better penetration into tumor tissues. Overall, this approach may lead to improved outcomes in patients with metastatic fibrosarcoma by providing a more precise and effective treatment option.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1695z | Mouse Anti-MTOR Recombinant Antibody (clone 35C1) | WB, ICC, IF, IHC | Mouse IgG1 |
MOB-0941MZ | Recombinant Mouse Anti-Human MTOR Antibody (clone 64F22) | ICC/IF | Mouse antibody |
ZG-0473U | Rabbit Anti-Phospho-MTOR (S2481) Recombinant Antibody (clone 3H11) | ELISA, WB, IF | Rabbit IgG |
VS3-FY973 | Recombinant Rabbit Anti-MTOR (phospho Ser2448) Antibody (clone R08-7G7) | WB, IHC-P | Rabbit IgG |
VS3-WK2163 | Rabbit Anti-MTOR (pS2481) Recombinant Antibody (clone R08-9E3) | WB | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY30. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.